Junya Zhao

Ms. Junya Zhao

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YWYanchi Wang
Yanchi Wang
JZJunya Zhao
Junya Zhao
NDNannan Duan
Nannan Duan
WLWei Liu
Wei Liu
YZYuxuan Zhang
Yuxuan Zhang
Desheng LiangDesheng Liang
Desheng Liang
Hemophilia B (HB) is an X-linked recessive bleeding disorder, caused by F9 gene deficiency. Gene therapy combined with the CRISPR/Cas9 technology offers a potential cure for hemophilia B. Now the Cas9 nickase (Cas9n) shows a great advantage in reducing off-target effect compared with wild-type Cas9. In this study, we found that in the multicopy ribosomal DNA (rDNA) locus, the homology directed recombination (HDR) efficiency induced by sgRNA-Cas9n was much higher than sgRNA-Cas9, meanwhile without off-target in six predicted sites. After co-transfection into mESCs with sgRNA-Cas9n and a non-viral rDNA targeting vector pMrnF9, harboring the homology donor template and the human F9 expression cassette, a recombination efficiency of 66.7% was achieved and all targeted clones were confirmed to be site-specific integration of F9 in the rDNA locus by PCR and southern blotting. Targeted mESCs retained the main pluripotent properties and were then differentiated into hepatic progenitor like cells (HPLCs) and mature hepatocytes, which were characterized by hepatic markers and functional assays. Importantly, the differentiated cells could transcribe exogenous F9 and secrete coagulation factor IX (FIX) proteins, suggesting active transcription and stable inheritance of transgenes in the rDNA locus. After intrasplenical transplantation in severe combined immune deficiency (SCID) mice, targeted HPLCs could survive and migrate from spleen to liver, resulting in secretion of exogenous FIX into blood. In summary, we demonstrate an efficient and site-specific gene targeting strategy in rDNA locus for stem cell-based gene therapy for hemophilia B.

Verified
Journal Article
Open access
PDF file
QTQiyu Tang
Qiyu Tang
ZHZhiqing Hu
Zhiqing Hu
JZJunya Zhao
Junya Zhao
TZTao Zhou
Tao Zhou
Shuqing TangShuqing Tang
Shuqing Tang
Desheng LiangDesheng Liang
Desheng Liang
Hemophilia B (HB) is an X-linked recessive disease caused by F9 gene mutation and functional coagulation factor IX (FIX) deficiency. Patients suffer from chronic arthritis and death threats owing to excessive bleeding. Compared with traditional treatments, gene therapy for HB has obvious advantages, especially when the hyperactive FIX mutant (FIX-Padua) is used. However, the mechanism by which FIX-Padua works remains ambiguous due to a lack of research models. Here, in situ introduction of F9-Padua mutation was performed in human induced pluripotent stem cells (hiPSCs) via CRISPR/Cas9 and single-stranded oligodeoxynucleotides (ssODNs). The hyperactivity of FIX-Padua was confirmed to be 364% of the normal level in edited hiPSCs-derived hepatocytes, providing a reliable model for exploring the mechanism of the hyperactivity of FIX-Padua. Moreover, the F9 cDNA containing F9-Padua was integrated before the F9 initiation codon by CRISPR/Cas9 in iPSCs from an HB patient (HB-hiPSCs). Integrated HB-hiPSCs after off-target screening were differentiated into hepatocytes. The FIX activity in the supernatant of integrated hepatocytes showed a 4.2-fold increase and reached 63.64% of the normal level, suggesting a universal treatment for HB patients with various mutations in F9 exons. Overall, our study provides new approaches for the exploration and development of cell-based gene therapy for HB.

Verified
Journal Article
Open access
PDF file
JZJunya Zhao
Junya Zhao
MZMiaojin Zhou
Miaojin Zhou
ZWZujia Wang
Zujia Wang
LWLingqian Wu
Lingqian Wu
ZHZhiqing Hu
Zhiqing Hu
Desheng LiangDesheng Liang
Desheng Liang
Hemophilia A (HA) is caused by mutations in the coagulation factor VIII (FVIII) gene (F8). Gene therapy is a hopeful cure for HA; however, FVIII inhibitors formation hinders its clinical application. Given that platelets promote coagulation via locally releasing α-granule, FVIII ectopically expressed in platelets has been attempted, with promising results for HA treatment. The B-domain-deleted F8 (BDDF8), driven by a truncated ITGA2B promoter, was targeted at the ribosomal DNA (rDNA) locus of HA patient-specific induced pluripotent stem cells (HA-iPSCs). The F8-modified, human induced pluripotent stem cells (2bF8-iPSCs) were differentiated into induced hematopoietic progenitor cells (iHPCs), induced megakaryocytes (iMKs), and mesenchymal stem cells (iMSCs), and the FVIII expression was detected. The ITGA2B promoter-driven BDDF8 was site-specifically integrated into the rDNA locus of HA-iPSCs. The 2bF8-iPSCs were efficiently differentiated into 2bF8-iHPCs, 2bF8-iMKs, and 2bF8-iMSCs. FVIII was 10.31 ng/106 cells in lysates of 2bF8-iHPCs, compared to 1.56 ng/106 cells in HA-iHPCs, and FVIII was 3.64 ng/106 cells in 2bF8-iMSCs lysates, while 1.31 ng/106 cells in iMSCs with CMV-driven BDDF8. Our results demonstrated a high expression of FVIII in iHPCs and iMSCs derived from hiPSCs with site-specific integration of ITGA2B promoter-driven BDDF8, indicating potential clinical prospects of this platelet-targeted strategy for HA gene therapy.

12 November 2021
Verified
Conference Paper
Closed access
YZYijia Zheng
Yijia Zheng
SLShengping Liu
Shengping Liu
XXXi Xu
Xi Xu
JZJunya Zhao
Junya Zhao
HWHaifeng Wang
Haifeng Wang
YZYanjie Zhu
Yanjie Zhu
Objective: Atrial fibrillation (AF) is a common cause of cerebral infarction resulting from thromboembolism. The left atrial appendage (LAA) is the main location of thrombus formation. The objective of this study is to quantify the morphological structure of pectinate muscles inside LAA using fractal analysis. Methods: In this study, fractal analysis of pectinates muscles consists of two steps. The first step was image segmentation using the region growing method based on grayscale to extract the border of LAA. Then the fractal dimension (FD) of the border of LAA was calculated using box-counting method. This quantitative analysis was assessed via both healthy volunteers $\boldsymbol{(n=7, \text { age: } 61 \pm 5, \text { male, } 5)}$ and thrombus patients $(\mathbf{n}\boldsymbol{=3,} \mathbf{age}\boldsymbol{: 63\pm 6,}$ male, 2). Mann Whitney U test was used for statistical analysis. Results: For image segmentation, the region growing method successfully segmented the borders of LAA for all volunteers and patients. The FD values of healthy groups and thrombus groups were $\boldsymbol{1.179\pm 0.005}$ and $\boldsymbol{1.113\pm 0.006}$ , respectively. The mean FD value of healthy groups was higher than in thrombus groups (p < 0.0001). Conclusion: Fractal analysis provides an effective measurement to quantify the complexity of pectinate muscles inside LAA and has the potential to distinguish thrombus patients from health.